Company Filing History:
1 out of 43 
1 out of 14 Years Active: 2015
Title: Kim Beauregard: Innovator in Peptidomimetics
Introduction
Kim Beauregard is a talented inventor based in Boucherville, Canada, known for her groundbreaking work in the field of peptidomimetics. She holds a patent that highlights her innovative approach to modulating biological activity through novel compounds and their therapeutic applications.
Latest Patents
Kim's most notable patent is titled "Peptidomimetics comprising N-amino cyclic urea residues and uses thereof." This patent discloses novel peptidomimetics that incorporate N-amino cyclic urea residues. These compounds are particularly significant as they have been shown to modulate the activity of CD36 or the IL-1 receptor in cells, offering potential treatments for diseases, disorders, or conditions related to these targets.
Career Highlights
Throughout her career, Kim has made significant contributions while working with various organizations, including Valorisation-Rcherche Limited Partnership and Rsem Limited Partnership. Her expertise has been invaluable in advancing research related to her inventive work, particularly in health and biological sciences.
Collaborations
Kim has collaborated with notable individuals in the field, including William A. Lubell and Sylvain Chemtob. These partnerships have enriched her research endeavors and have played a vital role in the development of her patented inventions.
Conclusion
Kim Beauregard exemplifies the innovative spirit in the scientific community. Her work on peptidomimetics demonstrates the impact that dedicated inventors can have on medicine and therapeutic development. With her patent, Kim continues to pave the way for future research and advancements in treating CD36- or IL-1-related conditions.